Saturday, January 13th the award ceremony of the Sant’Ilario Prize (2018 edition) was held at the Paganini Auditorium in Parma.
Prof. Paolo Colombo, Professor emeritus of the University of Parma and CEO of Plumestars, has received the certificate of civic merit for the very high research activity in the field of pharmaceutical technology and for the fundamental contribution in the development of the most modern technologies and innovative products with the achievement of fundamental patents for the sector with recognition of numerous international awards and honors.
Read more “Prof. Paolo Colombo receives the certificate of civic merit for pharmaceutical research on the occasion of the Premio Sant’Ilario 2018”
Dr. Francesca Buttini, researcher at the Department of Food and Drug Sciences of the University of Parma, received the “Emerging Scientist Award” from the “Aerosol Society UK“. The award was presented at the Drug Delivery to the Lungs congress dedicated to the pulmonary administration of drugs held in Edinburgh from 6 to 8 December, during which Dr Buttini gave a lecture on the results of her research.
Read more “To Francesca Buttini “Emerging Scientist Award” of the “Aerosol Society UK””
Plumestars attended the 2017 AAPS Annual Meeting & Exposition in San Diego presenting a poster on the last orphan medicine getting the EMA and FDA orphan designation. The orphan medicine presented was the powder of thalidomide prepared for both the oral and nasal administration.
Read more “12-15 November: AAPS Annual Meeting and Exposition in San Diego”
On Friday, November 10, at the Aula Magna of the University of Parma (Via Università 12), the meeting “Malignant pleural mesothelioma: preclinical and clinical research” will take place.
Read more “Conference “Malignant pleural mesothelioma: preclinical and clinical research” in Parma”
PlumeStars and Biopharmanet-Tec will attend together with the company Lisapharma spa The Eight World Congress of Orphan Medicines, in Barcelona on 14 and 15 November 2017.
The Congress brings together companies, start-ups and stakeholders in the field of orphan diseases and rare diseases.
Read more “14-15 November: the Eight World Congress of Orphan Medicinal Products in Barcelona”
Cardiovascular diseases, such as myocardial infarct and heart failure, represent a societal burden, accounting for more than 30% of deaths globally and spending yearly ~190 billion € in European healthcare. The chronic treatment of patients leads only to short-term benefits, since the conventional therapies show several weak points.
Read more “The nano-revolution reaches the heart: the EU-funded project CUPIDO”
On Friday, July 21, 2017, a Framework Agreement has been signed between the University of Parma and PlumeStars s.r.l. concerning a didactic and scientific collaboration between the Food and Drug Department and the start up PlumeStars.
Read more “Signed the Framework Agreement between the University of Parma and PlumeStars s.r.l.”
On June 8th, the 11th edition of the Innovation & Match 2017 was held, the intermediation event with bilateral meetings between companies, research centers and universities, organized by ASTER and Emilia-Romagna Enterprise Europe Network partners of the SIMPLER consortium.
The event took place within R2B – Research to Business 2017, the 12th edition of the International Industrial Research Exhibition, promoted by the Emilia-Romagna Region, Bologna Fiere, ASTER and SMAU.
Read more “Plumestars’ participation at R2B – Research to Business 2017 at Bologna Fiere”